Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 2 1

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 67Prostatic Neoplasms 49Multiple Myeloma 29Neoplasm Metastasis 27Osteoporosis 16Pain 15Carcinoma, Non-Small-Cell Lung 10Neoplasms 9Lung Neoplasms 8Osteosarcoma 7Neoplasms, Plasma Cell 7Neuroblastoma 6Carcinoma, Renal Cell 6Bone Diseases, Metabolic 6Humoral Hypercalcemia Of Malignancy 5Bone Neoplasms 5Fractures, Bone 4Bone Diseases 4Sarcoma, Ewing 3Sarcoma 3Lymphoma 3Kidney Neoplasms 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Spinal Cord Compression 2Small Cell Lung Carcinoma 2Rhabdomyosarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pleural Effusion, Malignant 2Ovarian Neoplasms 2

Interventions

Zoledronic Acid 2Surveys and Questionnaires 1Magnetic Resonance Spectroscopy 1Interviews as Topic 1Ferrosoferric Oxide 1Arthroplasty, Replacement, Hip 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Interventional × Osteonecrosis × Zoledronic Acid × Clear all
NCT02286830 2023-02-17

Magnolia

Odense University Hospital

Phase 4 Completed
158 enrolled
Plasma cell

Multiple Myeloma, Osteolysis, Osteonecrosis

NCT02632903 2018-08-22

Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

Children's Hospital of Eastern Ontario

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

Osteonecrosis, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡